Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.
about
The Obesity-Breast Cancer Conundrum: An Analysis of the IssuesSteroid hormones, steroid receptors, and breast cancer stem cellsmRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancerLive multicellular tumor spheroid models for high-content imaging and screening in cancer drug discovery.Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance.Loss of primary cilia occurs early in breast cancer development.Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease.Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.High-throughput imaging: Focusing in on drug discovery in 3D.Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PKSteroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin.Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.Impact of progesterone on stem/progenitor cells in the human breast.Progesterone stimulates progenitor cells in normal human breast and breast cancer cells.Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.The Role of Steroid Hormones in Breast and Effects on Cancer Stem Cells.
P2860
Q26747486-AAA499DE-FCB2-48ED-A5A3-3ED2265FB994Q26799113-81760CBF-7717-4EC6-B7ED-988B7280F350Q28543647-80503DF9-C002-4052-9915-3E89CD43C868Q30573300-6B010377-FACB-4A49-8333-5E9CD8E6930FQ33566693-91409C8E-CAB1-48FC-B157-CFCAD476E573Q33827521-FDC63B5A-0CB9-4433-82A4-CB33578E81B0Q34483718-69DEACBE-6AB1-49EB-8E7E-0796352EA7FAQ35205643-F54F5423-30BE-41D7-9A98-9839426349C5Q35853192-16288F01-031C-4481-9058-21BD7E49B8A1Q36688106-A6F1408A-C72D-40FE-AFBD-03873B5E8292Q36707715-A905D262-E478-4B21-BAC6-D52D3BC2418EQ37364468-99F3F72E-4253-4D85-9890-B3821134EA0FQ37689956-C53C5606-944C-4506-A76F-F95DE3B5FF3FQ38373935-B88F67F7-C854-4A9E-B615-78025160DE0DQ38562815-88139C11-1C6B-4F10-84E2-2C43621FF709Q39036993-34457051-D4C0-4CDE-8792-FA05F0AE437FQ47101494-A27C1649-A17F-42DE-BA9A-FD77564D9C2DQ52620231-3C7CCE9E-4732-40E8-9B0F-C040627E39F1
P2860
Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Progesterone-inducible cytoker ...... exhibit progenitor properties.
@ast
Progesterone-inducible cytoker ...... exhibit progenitor properties.
@en
type
label
Progesterone-inducible cytoker ...... exhibit progenitor properties.
@ast
Progesterone-inducible cytoker ...... exhibit progenitor properties.
@en
prefLabel
Progesterone-inducible cytoker ...... exhibit progenitor properties.
@ast
Progesterone-inducible cytoker ...... exhibit progenitor properties.
@en
P2093
P2860
P1433
P1476
Progesterone-inducible cytoker ...... exhibit progenitor properties.
@en
P2093
Byong Hoon Yoo
Carol A Sartorius
Daniel V Labarbera
Jerome Schaack
Peter Kabos
Rachel B Rosen
Sunshine Daddario Axlund
P2860
P2888
P356
10.1007/S12672-012-0127-5
P577
2012-11-27T00:00:00Z